0001144204-19-031917.txt : 20190621 0001144204-19-031917.hdr.sgml : 20190621 20190621170122 ACCESSION NUMBER: 0001144204-19-031917 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190620 FILED AS OF DATE: 20190621 DATE AS OF CHANGE: 20190621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ren Ken Keyong CENTRAL INDEX KEY: 0001545181 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20713 FILM NUMBER: 19912247 MAIL ADDRESS: STREET 1: 9640 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CASI Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0000895051 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 581959440 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9620 MEDICAL CENTER DR STREET 2: STE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-864-2600 MAIL ADDRESS: STREET 1: 9620 MEDICAL CENTER DR STREET 2: STE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: ENTREMED INC DATE OF NAME CHANGE: 19960415 4 1 tv524055_4.xml OWNERSHIP DOCUMENT X0306 4 2019-06-20 0 0000895051 CASI Pharmaceuticals, Inc. CASI 0001545181 Ren Ken Keyong CASI PHARMACEUTICALS, INC. 9620 MEDICAL CENTER DR. SUITE 300 ROCKVILLE MD 20850 1 0 0 0 Stock Option (Right to Buy) 3.13 2019-06-20 4 A 0 51538 0 A 2029-06-20 Common Stock 51538 51538 D Stock option award will vest ratably quarterly to the end of the year. /s/Cynthia W. Hu, attorney-in-fact for Ken K. Ren 2019-06-21